Greater Transparency For Medicare Advantage Program Needed, MDMA Says

The US government needs to provide more transparency for industry and payers into its oversight of Medicare Advantage (MA) programs, the Medical Device Manufacturers Association (MDMA) said.

In a 13 February letter to the Center for Medicare and Medicaid Services (CMS) Administrator, MDMA expressed its concerns...